Artificial Intelligence in Genomics Market Analysis
The global Artificial Intelligence in Genomics Market, valued at USD 726.9 million in 2023, is projected to reach USD 15.007 billion by 2031. This substantial growth is expected to occur at a compound annual growth rate (CAGR) of 46.0% from 2024 to 2031, according to the latest market analysis.
Artificial intelligence (AI) is increasingly revolutionizing the field of genomics by enabling advanced data analysis, interpretation, and personalized medicine approaches. The market's robust growth is driven by the rising demand for precision medicine, advancements in genomic sequencing technologies, and the need for efficient data management solutions.
Key Factors Driving Market Growth:
By Component
By Technology
By Functionality
By Application
By End-Use
Future Outlook:
The Artificial Intelligence in Genomics Market is poised for significant growth, driven by technological advancements and the increasing adoption of personalized medicine approaches. The integration of AI with genomic research is set to further enhance market growth, providing unprecedented opportunities for innovation and improving patient care.
Biopharmaceutical CMO Market size
Antipsychotic Drugs Market size
Breast Cancer Therapeutics Market size
At present there are zero comments on this article.
Why not be the first to make a comment?
There are zero sub-categories in this parent category.
There are zero sub-categories in this parent category.